Keryx's Q4 Loss Misses Expectation, Auryxia In Focus - February 27, 2015
February 27, 2015 at 09:21 AM EST
Keryx Biopharmaceuticals Inc. is a New York-based biopharmaceutical company working in the field of renal diseases. The company entered this field with the launch of its first product, Auryxia in Dec 2014
